Cambridge Epigenetix has now raised $56.5m from investors including the university and Alphabet’s GV for its epigenetics-powered diagnostic platform.

Synthorx's artificial genetic DNA pairings are expected to support the administration of an immuno-oncology drug previously hindered by safety issues.

Existing investors Edwards Lifesciences and Johnson & Johnson contributed to a round that took the medical device developer's total funding to almost $105m.

Bertelsmann-backed learning assistance platform Knowbox has received series C funding from returning investor Tal Education Group and Yunfeng Capital.

SoftBank Ventures Korea and CE Ventures added $10m to the sports analytics technology developer's Verizon-backed first close last June.

Qualcomm Ventures returned to back the virtual helathcare platform's series C round, bringing its overall funding to $160m.

Amazon has supplied $22m to help the business lending platform boost its latest round to $67m and its overall funding to almost $110m.

The Autodesk-backed 3D printer developer increased its overall funding to $85m in a series C round that will support growth in Asia.